Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 49 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Plain-language summary

Early identification of individuals at increased risk of mild cognitive impairment (MCI), a pre-dementia state, can provide a critical window for prompt intervention to prevent or reverse disease progression. Method A longitudinal cohort design (target sample size =200) was utilised to continuously gather information on behaviours associated with the performance of daily tasks and activities related to cognitive and physical function over three years. Results We present preliminary findings from 87 participants (37 MCI, 50 HC; Mage=76.15, SDage=6.20; 74.71% female). Participants with MCI had significantly poorer scores on the MoCA (MMCI=20.62, SDMCI=4.31; MHC=24.08, SDHC=4.23, p<.001) as compared to those with HC. There were no significant differences for the MMSE (MMCI=26.40, SDMCI=2.61; MHC=27.14, SDHC=2.21, p=.160), Geriatric Depression Scale (MMCI=1.35, SDMCI=1.45; MHC=0.84, SDHC=1.20, p=.086), and Pittsburg Sleep Quality Index Scores (MMCI = 10.42, SDMCI =2.73; MHC = 10.40, SDHC =2.55, p=.974). We observed that MCI participants were less active, had fewer daily steps, had a higher frequency of leaving personal belongings at home, and had a shorter total sleep time. We found that FusionART produces the highest level of performance across all three measures of precision, recall and F1 scores (0.91).

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 87 participants. This ongoing study uses in-home sensors and artificial intelligence to try to detect mild cognitive impairment early, and reports preliminary findings from 87 participants. Reported effect size: 74.71%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rawtaer, I., Jabbar, K. B. A., Subagdja, B., Saffari, E., & Tan, A. (2025). 299. SENSORS IN-HOME FOR ELDER WELLBEING (SINEW): DIGITAL PHENOTYPING AND ARTIFICIAL INTELLIGENCE FOR EARLY DETECTION OF DEMENTIA. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf052.136

Vancouver

Rawtaer I, Jabbar KBA, Subagdja B, Saffari E, Tan A. 299. SENSORS IN-HOME FOR ELDER WELLBEING (SINEW): DIGITAL PHENOTYPING AND ARTIFICIAL INTELLIGENCE FOR EARLY DETECTION OF DEMENTIA. The International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf052.136.

BibTeX

@article{rawtaer2025-f66c6bec,
  author  = {Rawtaer, Iris and Jabbar, Khalid Bin Abdul and Subagdja, Budhitama and Saffari, Ehsan and Tan, Ah‐Hwee},
  title   = {{299. SENSORS IN-HOME FOR ELDER WELLBEING (SINEW): DIGITAL PHENOTYPING AND ARTIFICIAL INTELLIGENCE FOR EARLY DETECTION OF DEMENTIA}},
  journal = {The International Journal of Neuropsychopharmacology},
  year    = {2025},
  doi     = {10.1093/ijnp/pyaf052.136},
  url     = {https://doi.org/10.1093/ijnp/pyaf052.136}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This ongoing study uses in-home sensors and artificial intelligence to try to detect mild cognitive impairment early, and reports preliminary findings from 87 participants. It is a detection study only and does not test any treatment, cure or prevention.

Study details

How this study scored 49/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 49 of 100.49 of 100 points earned51 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (The International Journal of Neuropsychopharmacology)
Journal's citation record 2 / 4 The International Journal of Neuropsychopharmacology: journal h-index 156 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 87 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Ah‐Hwee Tan: h-index 41 (OpenAlex, whole career)
Institution's track record 1 / 3 National University of Singapore: institution h-index 1,166 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 49 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Digital health tools from nearby years

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Digital health tools

See all studies in Digital health tools →